Literature DB >> 29516164

Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung.

Anna Caliò1, Maria Cecilia Mengoli2, Alberto Cavazza2, Giulio Rossi3, Claudio Ghimenton1, Matteo Brunelli1, Maurizio Pea4, Marco Chilosi5, Lisa Marcolini5, Guido Martignoni6,7.   

Abstract

Clear cell "sugar" tumor is a rare benign neoplasm arising in the lung, considered as a part of the PEComa family. As PEComas of other sites, this tumor expresses melanocytic markers such as HMB45 and Melan-A. Despite cathepsin K, MITF and CD68 staining are known to be positive in a large number of PEComas and TFE3 rearrangement has been reported in a subset of PEComas, no data is available regarding the expression of these markers and the occurrence of TFE3 and TFEB rearrangement in clear cell "sugar" tumor of the lung. We have investigated the immunolabeling of cathepsin K, MITF, and CD68 in five cases of clear cell "sugar" tumor. Moreover, we have also sought the presence of TFE3 and TFEB rearrangement by fluorescence in situ hybridization (FISH) assay. In all tumors, strong immunoreactivity of cathepsin K and CD68 (PG-M1 and KP1 clone) was demonstrated, whereas none of them labeled for MITF staining and showed TFE3 or TFEB rearrangement. These findings widen the immunohistochemical profile of clear cell "sugar" tumor providing useful new markers for challenging cases. The expression of lysosomal markers, such as cathepsin K and CD68, strengthens the hypothesis that this tumor is part of the PEComa family.

Entities:  

Keywords:  Cathepsin K; Clear cell “sugar” tumor; Immunohistochemistry; PEComa

Mesh:

Substances:

Year:  2018        PMID: 29516164     DOI: 10.1007/s00428-018-2325-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  PEC and sugar.

Authors:  F Bonetti; M Pea; G Martignoni; G Zamboni
Journal:  Am J Surg Pathol       Date:  1992-03       Impact factor: 6.394

2.  A distinctive subset of PEComas harbors TFE3 gene fusions.

Authors:  Pedram Argani; Sebastian Aulmann; Peter B Illei; George J Netto; Jae Ro; Hyun-yee Cho; Snjezana Dogan; Marc Ladanyi; Guido Martignoni; John R Goldblum; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

3.  Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression.

Authors:  Naoto Kuroda; Masakazu Goda; Dmitry V Kazakov; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Pathol Int       Date:  2009-10       Impact factor: 2.534

4.  Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction.

Authors:  Izabela Malinowska; David J Kwiatkowski; Sharon Weiss; Guido Martignoni; George Netto; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

5.  A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.

Authors:  Chisato Ohe; Naoto Kuroda; Ondrej Hes; Michal Michal; Tomas Vanecek; Petr Grossmann; Yukichi Tanaka; Mio Tanaka; Hidekazu Inui; Yoshihiro Komai; Tadashi Matsuda; Yoshiko Uemura
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

6.  Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.

Authors:  Mio Tanaka; Keisuke Kato; Kiyoshi Gomi; Masae Matsumoto; Hironori Kudo; Masato Shinkai; Youkatsu Ohama; Hisato Kigasawa; Yukichi Tanaka
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

7.  Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Stefano Gobbo; Giuseppe Zamboni; Marco Chilosi; Franco Bonetti
Journal:  Arch Pathol Lab Med       Date:  2010-01       Impact factor: 5.534

8.  Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC).

Authors:  F Bonetti; M Pea; G Martignoni; C Doglioni; G Zamboni; P Capelli; P Rimondi; A Andrion
Journal:  Pathology       Date:  1994-07       Impact factor: 5.306

9.  t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.

Authors:  Anna Caliò; Matteo Brunelli; Diego Segala; Serena Pedron; Regina Tardanico; Andrea Remo; Stefano Gobbo; Emanuela Meneghelli; Claudio Doglioni; Ondrej Hes; Claudia Zampini; Pedram Argani; Guido Martignoni
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

10.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

View more
  2 in total

Review 1.  Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers.

Authors:  Die Qian; Lisha He; Qing Zhang; Wenqing Li; Dandan Tang; Chunjie Wu; Fei Yang; Ke Li; Hong Zhang
Journal:  Curr Oncol       Date:  2022-08-22       Impact factor: 3.109

2.  Myopericytoma arising from myopericytosis-a hitherto unrecognized entity within the lung.

Authors:  Ulrike Gruber-Moesenbacher; Alicia Morresi-Hauff; Katja Behr; Helmut Popper
Journal:  Virchows Arch       Date:  2020-11-26       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.